Zur Institute, INNOVATIVE RESOURCES and ONLINE CONTINUING EDUCATION Sign In
New Users          

ONLINE CONTINUING EDUCATION FOR MENTAL HEALTH PROFESSIONALS

 

Substance Abuse, Drug Abuse & Chemical Dependency

Resources

This resource page is part of three Online Courses
Meth Inside Out: The Effect of Meth Addiction on Brain and Behavior & Windows to Recovery
Opiate Addiction: Effective and Promising Treatments
Substance Abuse & Chemical Dependency

Table Of Contents

 

 


Substance/Drug Addiction

Substance/Drug Abuse Treatment Centers

Addiction Center: Treatment centers are reviewed based on original research, interviews, public information and experiences of past residents.

Beachway Therapy Center

Betty Ford Center

Burning Tree

Casa Palmera

Hazelden

Las Encinas

Michael's House

Sierra Tuscon

The Ranch

The Recovery Village

 

Resources on Substance/Drug Abuse for the General Public

Alcoholics Anonymous
Narcotics Anonymous
NIDA: National Institute of Drug Abuse

NIDA Public Information Office: 301-443-1124
Inquiries about NIDA's treatment research activities: Division of Clinical and Services Research, 301-443-0107 (for questions regarding behavioral therapies) or 301-443-4060 (for questions regarding access to treatment, organization and management, and cost effectiveness); and, Medications Development Division, 301-443-6173 (for questions regarding medications development).

Center for Substance Abuse Treatment (CSAT)
CSAT, a part of the Substance Abuse and Mental Health Services Administration, is responsible for supporting treatment services through block grants and developing knowledge about effective drug treatment, disseminating the findings to the field, and promoting their adoption. CSAT also operates the National Treatment Referral 24-hour Hotline (1-800-662-HELP) which offers information and referral to people seeking treatment programs and other assistance. CSAT publications are available through the National Clearinghouse on Alcohol and Drug Information (1-800-729-6686). Additional information about CSAT can be found on their website.

Top of Page

 

Support Tools on Substance/Drug Abuse for the Addict or Alcoholic

NA Addiction Assessment tools: "Am I an Addict?"

AA Assessment Tools: "Is AA for you?"

 

Alternative Approaches to Drug Rehabilitation for Substance/Drug Abuse

Harm Reduction Resources

New View of Addiction and the War on Drugs

 

Decriminalization of 'Illegal Drugs'

Paying a high price for the war on drugs - In Monitor In Psychology 3/2014

Legalize It

 

Substance/Drug Abuse Resources for Clinician

Treatment Information:

Systemic Family Interventions (Joanne Tall's website)

Larry Fritzlan's information and articles on his recovery service.

SAMHSA info

Assessment Tools:

General
A comprehensive list of assessment instruments from the Alcohol & Drug Abuse Institute of the University of Washington, with a searchable database, many freely available on line.

Alcohol Assessment Instruments (downloadable)
Adult Warning of Alcohol Relapse

Alcohol Craving Questionnaire

Alcohol Outcome Expectancy Scale

Alcohol Expectancy Questionnaire for Adolescents

Cannabis assessment instruments (downloadable)
Adult cannabis problems questionnaire

Adolescent cannabis problems questionnaire

Cannabis use problems identification test

Cannabis withdrawal scale

Cocaine
Cocaine Selective Severity Assessment

CBT Supervision Tools:

Selected NIDA Educational Resources on Drug Addiction Treatment
The following are available from the National Clearinghouse on Alcohol and Drug Information (NCADI), the National Technical Information Service (NTIS), or the Government Printing Office (GPO). To order, refer to the NCADI (1-800-729-6686), NTIS (1-800-553-6847), or GPO (202-512-1800) number provided with the resource description.

Manuals and Clinical Reports:

Measuring and Improving Cost, Cost-Effectiveness, and Cost-Benefit for Substance Abuse Treatment Programs (1999). Offers substance abuse treatment program managers tools with which to calculate the costs of their programs and investigate the relationship between those costs and treatment outcomes. NCADI # BKD340. Available online at http://www.nida.nih.gov.

For clinicians treating women with Substance Abuse issues, please review TIP 51: Substance Abuse Treatment: Addressing the Specific Needs of Women

Measuring and Improving Cost, Cost-Effectiveness, and Cost-Benefit for Substance Abuse Treatment Programs (1999). Offers substance abuse treatment program managers tools with which to calculate the costs of their programs and investigate the relationship between those costs and treatment outcomes. NCADI # BKD340. Available online at http://www.nida.nih.gov.

An Overview of Prison and Community-Based Drug Abuse Treatment (1999). Summarizes substantive research on prison and community-based drug abuse treatment from the last 25 years and highlights how public health research can help inform public policies across systems. In press.

A Cognitive-Behavioral Approach: Treating Cocaine Addiction (1998). This is the first in NIDA's "Therapy Manuals for Drug Addiction" series. Describes cognitive behavioral therapy, a short-term focused approach to helping cocaine-addicted individuals become abstinent from cocaine and other drugs. NCADI # BKD254. Available online at http://www.nida.nih.gov.

A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction (1998). This is the second in NIDA's "Therapy Manuals for Drug Addiction" series. This treatment integrates a community reinforcement approach with an incentive program that uses vouchers. NCADI # BKD255. Available online at http://www.nida.nih.gov.

An Individual Drug Counseling Approach to Treat Cocaine Addiction: The Collaborative Cocaine Treatment Study Model (1999). This is the third in NIDA's "Therapy Manuals for Drug Addiction" series. Describes specific cognitive-behavioral models that can be implemented in a wide range of differing drug abuse treatment settings. NCADI # BKD337. Available online at http://www.nida.nih.gov.

Mental Health Assessment and Diagnosis of Substance Abusers: Clinical Report Series (1994). Provides detailed descriptions of psychiatric disorders that can occur among drug-abusing clients. NCADI # BKD148.

Relapse Prevention: Clinical Report Series (1994). Discusses several major issues to relapse prevention. Provides an overview of factors and experiences that can lead to relapse. Reviews general strategies for preventing relapses, and describes four specific approaches in detail. Outlines administrative issues related to implementing a relapse prevention program. NCADI # BKD147.

Addiction Severity Index Package (1993). Provides a structured clinical interview designed to collect information about substance use and functioning in life areas from adult clients seeking drug abuse treatment. Includes a handbook for program administrators, a resource manual, two videotapes, and a training facilitator's manual. NTIS # AVA19615VNB2KUS. $52.95.

Program Evaluation Package (1993). A practical resource for treatment program administrators and key staff. Includes an overview and case study manual, a guide for evaluation, a resource guide, and a pamphlet. NTIS # 95-167268. $44.00.

Relapse Prevention Package (1993). Examines two effective relapse prevention models, the Recovery Training and Self-Help (RTSH) program and the Cue Extinction model. NTIS # 95-167250. $62.00.

Research Monographs

Beyond the Therapeutic Alliance : Keeping the Drug-Dependent Individual in Treatment (Research Monograph 165) (1997). Reviews current treatment research on the best ways to retain patients in drug abuse treatment. NTIS # 97-181606. $47; GPO # 017-024-01608-0 $17. Available online at http://www.nida.nih.gov

Treatment of Drug-Exposed Women and Children: Advances in Research Methodology (Research Monograph 166) (1997). Presents experiences, products, and procedures of NIDA-supported Treatment Research Demonstration Program projects. NCADI # M166; NTIS # 96-179106. $49; GPO # 017-01592-0. $13. Available online at http://www.nida.nih.gov

Treatment of Drug-Dependent Individuals With Comorbid Mental Disorders (Research Monograph 172) (1997). Promotes effective treatment by reporting state-of-the-art treatment research on individuals with comorbid mental and addictive disorders and research on HIV-related issues among people with comorbid conditions. NCADI # M172; NTIS # 97-181580. $38; GPO # 017-024-01605. $9.

Medications Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials (Research Monograph 175) (1998). A state-of-the-art handbook for clinical investigators, pharmaceutical scientists, and treatment researchers. NCADI # M175.

Videos

Adolescent Treatment Approaches (1991). Emphasizes the importance of pinpointing and addressing individual problem areas, such as sexual abuse, peer pressure, and family involvement in treatment. Running time: 25 min. NCADI # VHS40. $12.50.

NIDA Technology Transfer Series: Assessment (1991). Shows how to use a number of diagnostic instruments as well as how to assess the implementation and effectiveness o f the plan during various phases of the patient's treatment. Running time: 22 min. NCADI # VHS38. $12.50.

Drug Abuse Treatment in Prison: A New Way Out (1995). Portrays two comprehensive drug abuse treatment approaches that have been effective with men and women in State and Federal Prisons. Running time: 23 min. NCADI # VHS72. $12.50.

Dual Diagnosis (1993). Focuses on the problem of mental illness in drug-abusing and drug-addicted populations, and examines various approaches useful for treating dual-diagnosed clients. Running time: 27 min. NCADI # VHS58. $12.50.

LAAM: Another Option for Maintenance Treatment of Opiate Addiction (1995). Shows how LAAM can be used to meet the opiate treatment needs of individual clients from the provider and patient perspectives. Running time: 16 min. NCADI # VHS73. $12.50.

Methadone: Where We Are (1993). Examines issues such as the use and effectiveness of methadone as a treatment, biological effects of methadone, the role of the counselor in treatment, and societal attitudes toward methadone treatment and patients. Running time: 24 min. NCADI # VHS59. $12.50.

Relapse Prevention (1991). Helps practitioners understand the common phenomenon of relapse to drug use among patients in treatment. Running time: 24 min. NCADI # VHS37. $12.50.

Treatment Issues for Women (1991). Assists treatment counselors help female patients to explore relationships with their children, with men, and with other women. Running time: 22 min. NCADI # VHS39. $12.50.

Treatment Solutions (1999). Describes the latest developments in treatment research and emphasizes the benefits of drug abuse treatment, not only to the patient, but also to the greater community. Running time: 19 min. NCADI # DD110. $12.50.

Program Evaluation Package (1993). A practical resource for treatment program administrators and key staff. Includes an overview and case study manual, a guide for evaluation, a resource guide, and a pamphlet. NTIS # 95-167268. $44.

Relapse Prevention Package (1993). Examines two effective relapse prevention models, the Recovery Training and Self-Help (RTSH) program and the Cue Extinction model. NTIS # 95-167250. $62.

Top of Page

 

Dual Roles in Rehabilitation Communities

Resources on multiple roles in recovery

 

Other Substance/Drug Abuse Federal Resources

The National Clearinghouse for Alcohol and Drug Information (NCADI).
NIDA publications and treatment materials along with publications from other Federal agencies are available from this information source. Staff provide assistance in English and Spanish, and have TDD capability. Phone: 1-800-729-6686.

The National Institute of Justice (NIJ).
As the research agency of the Department of Justice, NIJ supports research, evaluation, and demonstration programs relating to drug abuse in the contexts of crime and the criminal justice system. For information, including a wealth of publications, contact the National Criminal Justice Reference Service by telephone (1-800-851-3420 or 1-301-519-5500).

 

Substance/Drug Abuse & Treatment References

  • Arndt, S., Acion, L., & White, K. (2013). How the states stack up: Disparities in substance abuse outpatient treatment completion rates for minorities. Drug & Alcohol Dependence132(3), 547-554.
  • Burrow-Sánchez, J. J., Meyers, K., Corrales, C., & Ortiz-Jensen, C. (2015). The influence of cultural variables on treatment retention and engagement in a sample of Mexican American adolescent males with substance use disorders. Psychology of Addictive Behaviors29(4), 969.
  • Burrow-Sánchez, J. J., Minami, T., & Hops, H. (2015). Cultural accommodation of group substance abuse treatment for Latino adolescents: Results of an RCT. Cultural Diversity and Ethnic Minority Psychology21(4), 571.
  • DeVerteuil, G., Wilton, R. D., & Klassen, S. (2017). Making clean and sober places: the intersections of therapeutic landscapes and substance abuse treatment. In A. Williams (Ed.), Therapeutic landscapes (pp. 103-120). London: Routledge.
  • DiClemente, C. C. (2017). Addiction and change: How addictions develop and addicted people recover (2nd Ed.). New York, NY: Guilford Publications.
  • Exploring the relationship between religious coping and spirituality among three types of collegiate substance abuse. Journal of Counseling & Development93(1), 70-79.
  • Feinstein, B. A., Dyar, C., & London, B. (2017). Are outness and community involvement risk or protective factors for alcohol and drug abuse among sexual minority women?. Archives of sexual behavior46(5), 1411-1423.
  • Fish, J. N., Maier, C. A., & Priest, J. B. (2015). Substance abuse treatment response in a Latino sample: The influence of family conflict. Journal of Substance Abuse Treatment49, 27-34.
  • Flentje, A., Heck, N. C., & Sorensen, J. L. (2015). Substance use among lesbian, gay, and bisexual clients entering substance abuse treatment: Comparisons to heterosexual clients. Journal of Consulting and Clinical Psychology83(2), 325.
  • Gielen, N., Krumeich, A., Tekelenburg, M., Nederkoorn, C., & Havermans, R. C. (2016). How patients perceive the relationship between trauma, substance abuse, craving, and relapse: A qualitative study. Journal of Substance Use21(5), 466-470.
  • Gifford, E. J., Sloan, F. A., Eldred, L. M., & Evans, K. E. (2015). Intergenerational effects of parental substance-related convictions and adult drug treatment court participation on children’s school performance. American Journal of Orthopsychiatry85(5), 452.
  • Giordano, A. L., Prosek, E. A., Daly, C. M., Holm, J. M., Ramsey, Z. B., Abernathy, M. R., & Sender, K. M. Wang, M. C., Wong, Y. J., Nyutu, P. N., Spears, A., & Nichols III, W. (2016). Suicide protective factors in outpatient substance abuse patients: religious faith and family support. The International Journal for the Psychology of Religion26(4), 370-381.
  • Kelly, J., Davis, C., & Schlesinger, C. (2015). Substance use by same sex attracted young people: Prevalence, perceptions and homophobia. Drug and Alcohol Review34(4), 358-365.
  • Kerr, D. L., & Oglesby, W. H. (2017). LGBT populations and substance abuse research: An overview. In J. B. VanGeest, T. P. Johnson, & S. A. Alemagno (Eds.), Research methods in the study of substance abuse (pp. 341-355). Cham, Switzerland: Springer.
  • Mennis, J., & Stahler, G. J. (2016). Racial and ethnic disparities in outpatient substance use disorder treatment episode completion for different substances. Journal of Substance Abuse Treatment63, 25-33.
  • Moos, R. H. (2017). Evaluating treatment environments: The quality of psychiatric and substance abuse programs. New York, NY: Routledge.
  • Neger, E. N., & Prinz, R. J. (2015). Interventions to address parenting and parental substance abuse: Conceptual and methodological considerations. Clinical psychology review39, 71-82.
  • Paris, R., Herriott, A., Holt, M., & Gould, K. (2015). Differential responsiveness to a parenting intervention for mothers in substance abuse treatment. Child Abuse & Neglect50, 206-217.
  • Roberts, N. P., Roberts, P. A., Jones, N., & Bisson, J. I. (2015). Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis. Clinical Psychology Review38, 25-38.
  • Sahker, E., Toussaint, M. N., Ramirez, M., Ali, S. R., & Arndt, S. (2015). Evaluating racial disparity in referral source and successful completion of substance abuse treatment. Addictive Behaviors48, 25-29.
  • Sanchez, R. P., & Bartel, C. M. (2015). The feasibility and acceptability of “Arise”: An online substance abuse relapse prevention program. Games for Health Journal4(2), 136-144.
  • Schäfer, I., Pawils, S., Driessen, M., Härter, M., Hillemacher, T., Klein, M. & Schneider, B. (2017). Understanding the role of childhood abuse and neglect as a cause and consequence of substance abuse: The German CANSAS network. European Journal of Psychotraumatology8(1), 1304114.
  • Senker, S., & Green, G. (2016). Understanding recovery: The perspective of substance misusing offenders. Drugs and Alcohol Today16(1), 16-28.
  • Spielman, E., Herriott, A., Paris, R., & Sommer, A. R. (2015). Building a model program for substance-exposed newborns and their families: From needs assessment to intervention, evaluation, and consultation. Zero to Three36(1), 47-55.
  • Stahler, G. J., Mennis, J., & DuCette, J. P. (2016). Residential and outpatient treatment completion for substance use disorders in the US: Moderation analysis by demographics and drug of choice. Addictive Behaviors58, 129-135.
  • Substance, A., Mental, H. S. A. U., & Office of the Surgeon General (US. (2016). Facing addiction in America: The Surgeon General's report on alcohol, drugs, and health. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK424857/
  • Thurgood, S. L., McNeill, A., Clark-Carter, D., & Brose, L. S. (2016). A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine & Tobacco Research18(5), 993-1001.
  • Velasquez, M. M., Crouch, C., Stephens, N. S., & DiClemente, C. C. (2015). Group treatment for substance abuse: A stages-of-change therapy manual (2nd. Ed.).  New York, NY: Guilford Publications.
  • Wills, T., Sussman, S., & McGurk, M. (2015). Identity development and substance use in adolescence. In The Oxford handbook of adolescent substance abuse. DOI: 10.1093/oxfordhb/9780199735662.001.0001

Top of Page

Meth Addiction

 General Information on Meth Use, Effects and Recovery Programs

For a comprehensive list of resources, as well as an overview and many more details of the Meth Inside Out program, go to www.methinsideout.com. In addition, a comprehensive list of resources for additional information can be found at the end of the Meth Inside Out handbook included with this course.

State and Regional Meth Educational and Treatment Resources

Meth Treatment and Other Resources for Gay People

  • Friends Research Institute, Inc. - Friends Research Institute provides free drug counseling as part of a research study for gay and bisexual men who use methamphetamine. The Institute created and published the gay-specific treatment manual, "Getting Off: A Behavioral Treatment Intervention for Gay and Bisexual Male Methamphetamine Users."
  • Friends Getting Off

Meth Videos & Multimedia

  • World's Most Dangerous Drug National Geographic Channel
  • The Addiction Project
  • Methamphetamine: New Knowledge, New Treatments
  • Methamphetamine: A Prevention Trilogy - California Department of Justice
  • Meth - Produced & Directed by Todd Ahlberg
  • Meth America - Directed by Christopher Halligan
  • Meth: Dark Cloud Over the Big Sky - PBS/Student Documentary Unit
  • American Meth - A Time & Tide Productions Project - Narrated by Val Kilmer
  • Methamphetamine 101: Etiology and Physiology of an Epidemic - Digital Training Module - Center for Applied Behavioral Health Policy
  • Methamphetamine 102: Introduction to Evidence-Based Treatments - Digital Training Module - Center for Applied Behavioral Health Policy

Additional References on Meth

  • Alammehrjerdi, Z., Ezard, N., Clare, P., Babhadiashar, B., Shakeri, A., & Mokri, A. (2016). Brief cognitive-behavioural therapy for methamphetamine use among methadone-maintained women: A multicentre randomised controlled trial. Journal of Addiction and Therapy Research7(4), 1-8. DOI: 10.4172/2155-6105.1000294
  • Arunogiri, S., Foulds, J. A., McKetin, R., & Lubman, D. I. (2018). A systematic review of risk factors for methamphetamine-associated psychosis. Australian & New Zealand Journal of Psychiatry, 0004867417748750. https://doi.org/10.1177/0004867417748750
  • Carrico, A. W., Nation, A., Gómez, W., Sundberg, J., Dilworth, S. E., Johnson, M. O., & Rose, C. D. (2015). Pilot trial of an expressive writing intervention with HIV-positive methamphetamine-using men who have sex with men. Psychology of Addictive Behaviors29(2), 277. http://dx.doi.org/10.1037/adb0000031
  • Ellis, C., Hoffman, W., Jaehnert, S., Plagge, J., Loftis, J. M., Schwartz, D., & Huckans, M. (2016). Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction. Addictive Disorders & Their Treatment15(1), 1. doi: 10.1097/ADT.0000000000000059
  • Glasner-Edwards, S., & Mooney, L. J. (2014). Methamphetamine psychosis: Epidemiology and management. CNS Drugs28(12), 1115-1126. https://doi.org/10.1007/s40263-014-0209-8
  • Hartwell, E. E., & Ray, L. (2017). Differences in clinical presentation between high and low impulsive methamphetamine users. Drug & Alcohol Dependence171, e83. DOI: https://doi.org/10.1016/j.drugalcdep.2016.08.235
  • Hayashi, H. D., Patterson, T. L., Semple, S. J., Fujimoto, K., & Stockman, J. K. (2016). Risk factors for recent intimate partner violence among methamphetamine-using men and women. Journal of Psychoactive Drugs48(2), 135-145. https://doi.org/10.1080/02791072.2016.117024
  • McKetin, R. (2018). Methamphetamine psychosis: Insights from the past. Addiction. Doi: 10.1111/add.14170
  • McKetin, R., Kothe, A., Baker, A. L., Lee, N. K., Ross, J., & Lubman, D. I. (2018). Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study. Drug and Alcohol Review37(1), 70-78. https://doi.org/10.1111/dar.12528
  • Saini, M., Magh, S., Ohri, N., & Singh, S. G. (2017). Methamphetamine: Symptoms under the bridge. Open Journal of Psychiatry & Allied Sciences8(1), 82-83. Retrieved from https://www.researchgate.net/.../Methamphetamine-Symptoms-under-the-bridge.pdf
  • Sheff, D. (2018). Beautiful Boy: A father's journey through his son's addiction. New York, NY: Simon and Schuster.
  • Shelly, J., Uhlmann, A., Sinclair, H., Howells, F. M., Sibeko, G., Wilson, D., & Temmingh, H. (2016). First-rank symptoms in methamphetamine psychosis and schizophrenia. Psychopathology49(6), 429-435. https://doi.org/10.1159/000452476

Top of Page

Opiate Addiction

Opiate Addiction Treatment Centers

Top of Page

Resources on Opiate Addiction for Clinicians

Resources on Opiate Addiction for the General Public

  • Narcotics Anonymous
  • National Institute on Drug Abuse
  • NIDA Public Information Office: 301-443-1124
    Inquiries about NIDA's treatment research activities: Division of Clinical and Services Research, 301-443-0107 (for questions regarding behavioral therapies) or 301-443-4060 (for questions regarding access to treatment, organization and management, and cost effectiveness); and, Medications Development Division, 301-443-6173 (for questions regarding medications development).
  • Center for Substance Abuse Treatment (CSAT)
    CSAT, a part of the Substance Abuse and Mental Health Services Administration, is responsible for supporting treatment services through block grants and developing knowledge about effective drug treatment, disseminating the findings to the field, and promoting their adoption. CSAT also operates the National Treatment Referral 24-hour Hotline (1-800-662-HELP) which offers information and referral to people seeking treatment programs and other assistance. CSAT publications are available through the National Clearinghouse on Alcohol and Drug Information (1-800-729-6686). Additional information about CSAT can be found on their website.
  • National Institute on Drug Abuse The latest reports on incidence, psychopharmacology of opioids, and treatments may be found here.
  • Treating Opioid Use During Pregnancy (2017).
  • Effective Treatments for Opioid Addiction (2016). A policy update on pharmacological treatments for opioid addiction from the National Institute on Drug Abuse.

Alternative Approaches to Drug Rehabilitation-Opiate Addiction

Podcasts & Videos on Opiate Addiction

  • Ecker, A. H., & Hundt, N. (2017, July 31). Posttraumatic Stress Disorder in Opioid Agonist Therapy: A Review. Psychological Trauma: Theory, Research, Practice, and Policy. Advance online publication. http://dx.doi.org/10.1037/tra0000312
  • Lejue, Car l W (2018), (DVD) .Functional Analysis and Behavioral Activation for Substance Use. Washington, DC: American Psychological Association

Additional References on Opiate Addiction

  • Becker, SJ, Squires, DD, Strong, DR et.al (2015). Training opioid addiction treatment providers to adopt contingency management: A prospective pilot trial of a comprehensive implementation science approach, Substance Abuse, 37:1,134-140
  • Blendon, Robert J & Benson, JM (2018). The Public and the Opioid-Abuse Epidemic, New England Journal of Medicine 378:407-411
  • Bochner, David, Somogyi, Andrew, et al (2017). Impaired psychomotor function and plasma methadone and levo-alpha-acetylmethadol (LAAM) concentrations in opioid substitution patients. Experimental and Clinical Psychopharmacology, 25(3):223-233
  • Cavaiola, Alan, Fulmer, Barbara & Stout, David (2015). The Impact of Social Support and Attachment Style on Quality of Life and Readiness to Change in a Sample of Individuals Receiving Medication-Assisted Treatment for Opioid Dependence, Substance Abuse, 36:2, 183-191
  • Comerci, George, Katzman, Joanna & Duhigg, Daniel (2018). Controlling the Swing of the Opioid Pendulum, New England Journal of Medicine 378:691-693
  • Fox, Aaron, Chamberlain, Adam, Frost, Taeko & Cunningham, Chinazo (2015). Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment, Substance Abuse, 36:2, 155-16
  • Gkegkes, Joannis, et al (2018). Oxycodone/naloxone in postoperative pain management of surgical patients, Journal of Opioid Management 14 (1) np
  • Mazer-Amirshahi, Maryann & Motov, Sergey (2018). Hydromorphone use for acute pain: Misconceptions, controversies, and risks, Journal of Opioid Management 14 (1) np
  • Moody, Lara N.; Satterwhite, Emily; Bickel, Warren K. (2017). Substance use in rural Central Appalachia: Current status and treatment considerations. Journal of Rural Mental Health 41 (2), 123-135 doi: http://dx.doi.org/10.1037/rmh0000064
  • Moore, Brent A.; Buono, Frank D.; Printz, Destiny M. B.; Lloyd, Daniel P.; Fiellin, David A.; Cutter, Christopher J.; Schottenfeld, Richard S.; & Barry, Declan T. (2017). Customized recommendations and reminder text messages for automated, computer-based treatment during methadone. Experimental and Clinical Psychopharmacology Vol 25(6), Dec 2017, 485-495 http://dx.doi.org/10.1037/pha0000149
  • Neale, Joanne, Tompkins, C. et.al. (2014). "You're all going to hate the word 'recovery' by the end of this": Service users' views of measuring addiction recovery, Drugs: Education, Prevention and Policy, 22:1,26-34
  • Newcombe, David A. L.; Somogyi, Andrew A.; Bochner, Felix; & White, Jason M. (2017). Experimental and Clinical Psychopharmacology Vol 25(3), Jun 2017, 223-233 http://dx.doi.org/10.1037/pha0000114
  • Parkman, Tom & Lloyd, Charlie (2016) How Intense Is Too Intense? A Qualitative Exploration of a Structured Day Treatment Program for Substance Dependency in the United Kingdom, Alcoholism Treatment Quarterly, 34:3, 274-291
  • Salas, Joann, Scherrer, Jeffrey, Lustman, Patrick & Schneider, F David (2015) Racial differences in the association between nonmedical prescription opioid use, abuse/dependence, and major depression, Substance Abuse, 37:1, 25-30
  • Scheier, Lawrence M. (ed). (2015). Handbook Of Adolescent Drug Use Prevention: Research, Intervention Strategies, And Practice, Washington, DC: American Psychological Association.
  • Shaffer, Howard J (ed) (2012). APA Addiction Syndrome Handbook. Washington, DC: American Psychological Association
  • Suzuki, Joi & Dodds, Tyler (2015) Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment, Substance Abuse, 37:1, 31-34
  • Worley, Matthew J.; Heinzerling, Keith G.; Shoptaw, Steven; & Ling, Walter. (2015). Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Experimental and Clinical Psychopharmacology Vol 23(6), 428-435 http://dx.doi.org/10.1037/pha0000039

Top of Page

 

Accommodations for Disabilities                   Clinical Updates Email Sign Up                  Refund & Course Exchange Policies


     

  APA NBCC NAADC ASWB

      Twitter Facebook LinkedIn YouTube

Online CE Courses
CE Board Approvals
60 Essential Clinical Forms
HIPAA Compliance Kit
Private Practice Handbook
Free Online Resources
Organizational Discounts
Site Map

Teaching
Consulting
Expert Witness
Issues Facing Teenagers
Boundaries & Dual Relationships
About Us
Info for the General Public
ADA Policy & Grievance
Privacy, Disclaimer, Terms of Use, DMCA


© 1995 - 2018 ZUR INSTITUTE, Inc.             Ofer Zur, Ph.D. Director             Contact Zur Institute, Inc.